Back

Little Evidence of Modified Genetic Effect of rs16969968 on Heavy Smoking Based on Age of Onset of Smoking

Adjangba, C.; Border, R.; Romero Villela, P. N.; Ehringer, M. A.; Evans, L. M.

2020-04-24 genetic and genomic medicine
10.1101/2020.04.22.20071407
Show abstract

Tobacco smoking is the leading cause of preventable death globally. Smoking quantity, measured in cigarettes per day (CPD), is influenced both by the age of onset of regular smoking (AOS) and by genetic factors, including a strong effect of the non-synonymous single nucleotide polymorphism rs16969968. A previous study by Hartz et al. reported an interaction between these two factors, whereby rs16969968 risk allele carriers who started smoking earlier showed increased risk for heavy smoking compared to those who started later. This finding has yet to be replicated in a large, independent sample. We performed a preregistered, direct replication attempt of the rs16969968xAOS interaction on smoking quantity in 128,383 unrelated individuals from the UK Biobank, meta-analyzed across ancestry groups. We fit statistical association models mirroring the original publication as well as formal interaction tests on multiple phenotypic and analytical scales. We replicated the main effects of rs16969968 and AOS on CPD but failed to replicate the interaction using previous methods. Nominal significance of the rs16969968xAOS interaction term depended strongly on the scale of analysis and the particular phenotype, as did associations stratified by early/late AOS. No interaction tests passed genome-wide correction (=5e-8), and all estimated interaction effect sizes were much smaller in magnitude than previous estimates. We failed to replicate the strong rs16969968xAOS interaction effect previously reported. If such gene-moderator interactions influence complex traits, they likely depend on scale of measurement, and current biobanks lack the power to detect significant genome-wide associations given the minute effect sizes expected. IMPLICATIONSWe failed to replicate the strong rs16969968xAOS interaction effect on smoking quantity previously reported. If such gene-moderator interactions influence complex traits, current biobanks lack the power to detect significant genome-wide associations given the minute effect sizes expected. Furthermore, many potential interaction effects are likely to depend on the scale of measurement employed.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Genetics
based on 72 papers
Top 1%
12.5%
2
Nature Communications
based on 483 papers
Top 7%
11.1%
3
The American Journal of Human Genetics
based on 77 papers
Top 2%
7.5%
4
Scientific Reports
based on 701 papers
Top 34%
5.3%
5
PLOS Genetics
based on 39 papers
Top 0.4%
4.7%
6
Cell Genomics
based on 34 papers
Top 0.7%
2.9%
7
Addiction
based on 24 papers
Top 1.0%
2.9%
8
Genetic Epidemiology
based on 14 papers
Top 0.1%
2.9%
9
Human Molecular Genetics
based on 28 papers
Top 0.9%
2.8%
50% of probability mass above
10
Nature
based on 58 papers
Top 3%
2.4%
11
Drug and Alcohol Dependence
based on 21 papers
Top 0.9%
2.4%
12
Translational Psychiatry
based on 94 papers
Top 5%
2.2%
13
Clinical Epigenetics
based on 21 papers
Top 0.8%
1.8%
14
Nature Medicine
based on 88 papers
Top 8%
1.6%
15
Proceedings of the National Academy of Sciences
based on 100 papers
Top 9%
1.3%
16
Genome Medicine
based on 56 papers
Top 5%
1.3%
17
Nature Human Behaviour
based on 18 papers
Top 1%
1.3%
18
eLife
based on 262 papers
Top 22%
1.3%
19
Biological Psychiatry
based on 36 papers
Top 4%
1.3%
20
Psychological Medicine
based on 52 papers
Top 6%
1.2%
21
International Journal of Epidemiology
based on 65 papers
Top 7%
1.2%
22
BMC Medical Genomics
based on 12 papers
Top 1.0%
0.8%
23
BMC Medicine
based on 155 papers
Top 22%
0.8%
24
Human Genetics and Genomics Advances
based on 39 papers
Top 3%
0.8%
25
PLOS ONE
based on 1737 papers
Top 95%
0.8%
26
PLOS Medicine
based on 95 papers
Top 15%
0.8%
27
Addiction Biology
based on 13 papers
Top 2%
0.8%
28
Thorax
based on 29 papers
Top 2%
0.8%
29
European Journal of Human Genetics
based on 25 papers
Top 2%
0.8%
30
eBioMedicine
based on 82 papers
Top 9%
0.7%